Outlook Therapeutics (OTLK) Change in Taxes (2015 - 2016)

Outlook Therapeutics (OTLK) reported Change in Taxes of $50000.0 for Q1 2016, little changed quarter-over-quarter from $50000.0 in Q4 2015.

Outlook Therapeutics (OTLK) Change in Taxes (2015 - 2016) Analysis & Trends

Outlook Therapeutics (OTLK) has 2 years of Change in Taxes data on file, last reported at $50000.0 in Q1 2016.

Change in Taxes for Q1 2016 came in at $50000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was $100000.0 (changed N/A YoY), and the FY2025 annual result was -$1.6 million, changed N/A from the prior year.
Change in Taxes held at $50000.0 in Q1 2016 per OTLK's latest filing, from $50000.0 in the prior quarter.
Over five years, Change in Taxes peaked at $50000.0 in Q4 2015 and troughed at $9745.0 in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change Taxes (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Outlook Therapeutics	51.56 Mn	43.81 Mn	-21,888.00	-

Download Data